Filter by: patients
Home > Community Treatment Reports and Side Effects > Mucodyne Treatment Report
What is Mucodyne?

Mucodyne is a name for the drug carbocysteine, a mucolytic agent, used to decrease excessive mucous production; may be used in acute or chronic bronchitis, rhinopharyngitis, tracheitis, acute or subacute laryngitis, otitis, and sinusitis. It is available in capsule or syrup formulations.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 2 0
Respiratory infections 2 1 Efficacy_moderate
Improve swallowing 1 0
Chest congestion 1 0
Bronchiectasis 1 0

See all 4 patients currently taking Mucodyne

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Dosages

  6 other daily 30 mg daily 45 mg daily 45 mL daily 750 mL daily 1,500 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Mucodyne (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 1   Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Mucodyne

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Mucodyne

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Mucodyne

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Mucodyne

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Mucodyne

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Mucodyne

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

Report created on May 26, 2012.